Hyperfine Q1 revenue up 25% to $3.30M; net loss narrows to $0.14/share

Hyperfine, Inc.

2024-Q1 EPS reported -$0.14 revenue$3,295,000

Revenue $3.30M, up 25% YoY from $2.64M; 13 commercial Swoop systems sold in Q1.
Net loss $9.85M ($0.14 loss per share), improved from $12.16M loss ($0.17) in Q1 2023.
Launched 8th gen AI software; began CARE PMR Alzheimer's study; >100 patients in stroke study.
Full-year 2024 revenue guidance $12-15M; cash burn guidance ~$40M.
Gross margin $1.35M; SG&A expense down 26% YoY to $6.43M; R&D $5.57M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Hyperfine, Inc. reported first quarter ended March 31, 2024 results: revenue $3.30 million, net income $9.85 million, EPS $0.14 per share. Guidance reaffirmed.

Period: first quarter ended March 31, 2024
Revenue: $3.30 million
Net income: $9.85 million
EPS: $0.14 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Stroke Conference and 17 at International Society for Magnetic Resonance Medicine. First Quarter 2024 Financial Results • Revenues for the first quarter of 2024 were $3.30 million, up 25%, compared to $2.64 million in the first quarter of 2023. • Hyperfine, Inc. sold 13 commercial Swoop® systems in the first quarter of 2024. • Gross margin for the first

View on SEC.gov

1047 earnings releases filed in the last 30 days. Browse all earnings releases →

Hyperfine, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-058664

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.